Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Pharmaceutics|January 25, 2025
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future ProspectsYu Lei, Jiacheng Liu, Yaowei Bai, et al.
Journal of Hepatocellular Carcinoma|November 26, 2025
CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After HepatectomyYu Lei, Yaowei Bai, Yang Su, et al.
Journal of Cancer|March 4, 2024
Impact of Sarcopenia on Prognosis in Primary Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Single Center Retrospective StudyYaowei Bai, Jiacheng Liu, Ying Wang, et al.
Current Medical Research and Opinion|September 17, 2025
Implantation, removal, and adjustment of the totally implantable venous access port under the guidance of digital subtraction angiography: a ten-year experience at a territory medical centerYingliang Wang, Huimin Zhou, Chen Zhou, et al.
Biomedical Materials (Bristol, England)|May 2, 2024
Recent advances in hepatocellular carcinoma-targeted nanoparticlesXiaoming Liu, Yaowei Bai, Binqian Zhou, et al.
International Journal of Nanomedicine|January 10, 2024
Synergistic Effects of Nanoscale CaO<sub>2</sub> Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising CombinationYingliang Wang, Shuguang Ju, Huimin Zhou, et al.
Magma (New York, N.Y.)|March 17, 2025
Using intra-voxel incoherent motion MRI to dynamically evaluate the attenuating effects of donafenib combined with carvedilol in a thioacetamide-induced hepatic fibrosis rat modelJiacheng Liu, Yaowei Bai, Wei Yao, et al.
Polymer Science & Technology (Washington, D.C.)|June 8, 2026
Polymeric Nanomaterials for Atherosclerosis Diagnosis and TreatmentXiaoming Liu, Kailu Zhang, Mingming Yin, et al.
Journal of Interventional Medicine|December 19, 2022
Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosisChaoyang Wang, Jinghong Yao, Huanzhang Niu, et al.
Heliyon|June 12, 2024
The time window for pre-emptive transjugular intrahepatic portosystemic shunt could be extended to 5 daysXiangjun Dong, Jiacheng Liu, Yaowei Bai, et al.
Pageof 6